December 12, 2024 – Panama City, Panama
PoSciDonDAO, an emerging organization in the DeSci (decentralized science) domain, has announced the launch of a DAO (decentralized autonomous organization) dedicated to funding personalized medicine research.
Leveraging blockchain technology, PoSciDonDAO aims to improve efficiencies and transparency in research funding while enabling global collaboration to address life-altering diseases such as cancer, multiple sclerosis and Alzheimer’s disease.
A vision for advancing patient care
Personalized medicine, which tailors treatments to patients based on genetic and molecular profiles, offers a path toward more effective therapies and better patient outcomes.
This field has been hindered by limited funding and systemic inefficiencies.
PoSciDonDAO’s mission is to address these challenges by providing resources to explore novel approaches such as viro-immunotherapies and gene and cell therapies.
By funding early-stage, pre-patented research, PoSciDonDAO seeks to drive innovation from academic labs to commercial viability.
This initiative is designed to improve healthcare outcomes for patients worldwide by advancing patient-tailored therapies and making innovative treatments more accessible.
Empowering community governance
PoSciDonDAO introduces incentive models to foster long-term engagement among scientists, innovators and DeSci enthusiasts.
Its governance framework enables community members to actively participate in DAO operations and funding decisions, ensuring resources are allocated to projects aligned with the shared goal of advancing personalized medicine.
Building partnerships in DeSci
Since its inception, PoSciDonDAO has been an active participant in DeSci discussions and collaborations.
Notably, it engages with other DeSci initiatives such as the Health Data Alliance which includes projects like AxonDAO, DataLake and Hippocrat underscoring its commitment to advancing the DeSci movement.
More partnerships and collaborations will be announced in the near future.
About PoSciDonDAO
By combining blockchain technology with scientific innovation, PoSciDonDAO is establishing a collaborative platform for research in personalized medicine.
This approach aims to accelerate discoveries and democratize access to resulting treatments, benefiting patients and healthcare systems globally.
The PoSciDonDAO team includes experts in virology, immunology, oncology, epidemiology and Web 3.0.
With in-house expertise and contributions from its community members, the DAO can identify which projects have the most potential to impact the personalized medicine field.
The PoSciDonDAO token, SCI, is central to the DAO’s governance model, allowing community members to participate in decision-making processes.
This decentralized and transparent mechanism ensures resources are directed toward impactful research projects.
For more information about PoSciDonDAO, users can visit the official PoSciDonDAO website.
Joining the community
PoSciDonDAO offers scientists, innovators and DeSci enthusiasts to become part of this transformative initiative.
By advancing research in personalized medicine, PoSciDonDAO aims to contribute to improved therapies and better outcomes for patients worldwide.
Disclaimer
The information provided herein is for informational or educational purposes only and does not constitute financial, legal or tax advice.
Any purchase, sale or other transaction related to SCI tokens is undertaken at the sole discretion and risk of the participant.
PoSciDonDAO does not assume responsibility for any loss, damages or other consequences arising out of such transactions.
The SCI token is not and shall not be offered or sold to persons in the United States or individuals/entities on OFAC sanctioned lists.
Further, this release does not constitute an offer to sell or a solicitation of an offer to buy any securities or financial instruments in any jurisdiction.
Participants are strongly encouraged to conduct their own due diligence and seek independent advice from qualified legal, tax or financial advisors before engaging with SCI tokens, blockchain technology and digital assets generally.
Participation in any token-related activities is subject to compliance with applicable laws, regulations, reporting and eligibility requirements, including KYC/AML processes.
PoSciDonDAO makes no guarantees or promises regarding the future performance, value or regulatory compliance of the SCI tokens.
Contact
Ayat Abourashed, marketing representation for PoSciDonDAO Foundation
This content is sponsored and should be regarded as promotional material. Opinions and statements expressed herein are those of the author and do not reflect the opinions of The Daily Hodl. The Daily Hodl is not a subsidiary of or owned by any ICOs, blockchain startups or companies that advertise on our platform. Investors should do their due diligence before making any high-risk investments in any ICOs, blockchain startups or cryptocurrencies. Please be advised that your investments are at your own risk, and any losses you may incur are your responsibility.
Follow Us on Twitter Facebook Telegram
Source link
Chainwire
https://dailyhodl.com/2024/12/12/poscidondao-unveils-a-decentralized-future-for-personalized-medicine-research/
2024-12-12 19:22:57
